Pharmacy Times

NOVEMBER 9, 2023

Women with inflammation during COVID-19 infection are at higher risk for Long Covid symptoms, according to study results.

175

175

STAT

NOVEMBER 9, 2023

In my decade living in Silicon Valley as a digital health journalist and now an investor, I can’t tell you how many times I’ve heard people in the tech industry claim that doctors don’t have what it takes for a career in entrepreneurship. As the traditional thinking goes, because they’re so risk-averse and lack business training, physicians are not well suited to a high-growth, venture-backed startup environment.

144

144

Pharmacy Times

NOVEMBER 9, 2023

Pharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.

153

153

STAT

NOVEMBER 9, 2023

A panel of government advisers finally has endorsed ideas for Congress to solve the particularly thorny problem of surprise ambulance bills , including a cap on how much patients would have to pay if they took an ambulance. Surprise bills have been eliminated for most health care services, but people who take out-of-network ground ambulances remain broadly unprotected — facing potentially thousands of dollars and the threat of collections for a ride that nobody really asks for.

Hospitals 144

Hospitals 144

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

NOVEMBER 9, 2023

Perfluorohexyloctane is the first and only treatment that targets tear evaporation to provide relief for dry eye disease

145

145

STAT

NOVEMBER 9, 2023

Maybe probiotics would have saved my son’s life. I’ll never know because when I asked Micah’s care team to consider probiotics to counter the deluge of antibiotics, I was dismissed as senseless. My son Micah was born at 27 weeks gestation, weighing just over 2 pounds, with a head full of thick, wavy hair. By 6 weeks old, Micah weighed 5 pounds, was beginning to nurse, and was progressing toward discharge.

FDA 142

FDA 142

STAT

NOVEMBER 9, 2023

When Jason Farley was growing up in rural Alabama as a young gay man, he faced a lot of prejudice. “Everything I heard was like I was going to wake up one day and God was going to smite me with AIDS,” he said.

141

141

Pharmacy Times

NOVEMBER 9, 2023

With this approval, fruquintinib is the first and only selective inhibitor of all 3 VEGR receptor kinases to be approved in the United States for previously treated mCRC, regardless of biomarker status.

FDA 139

FDA 139

STAT

NOVEMBER 9, 2023

Apple has for years promised that its devices can help people live healthier, but it has so far produced little concrete evidence of this benefit. Many of the company’s health tools are consumer features without strong ties to the health care system, so there often isn’t a health care outcome to measure as proof. Nevertheless, Apple has embarked on several systematic studies exploring how its devices might be used to more directly improve health conditions, and after several years,

Insurance 139

Insurance 139

Pharmacy Times

NOVEMBER 9, 2023

Launching development of SOPs and communication with wholesalers is key.

Communication 136

Communication 136

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

NOVEMBER 9, 2023

NEW YORK — Surgeons have performed the world’s first transplant of an entire human eye, an extraordinary addition to a face transplant — although it’s far too soon to know if the man will ever see through his new left eye. An accident with high-voltage power lines had destroyed most of Aaron James’ face and one eye.

139

139

Pharmacy Times

NOVEMBER 9, 2023

Preventative drug lists were associated with a modest increase in adherence to combination inhaled corticosteroid long-acting β2-agonists.

132

132

STAT

NOVEMBER 9, 2023

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them.

124

124

Pharmacy Times

NOVEMBER 9, 2023

Socioeconomic, racial, and insurance disparities impact individuals' health before and after receiving surgery to treat adolescent idiopathic scoliosis.

Insurance 130

Insurance 130

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Topics

NOVEMBER 9, 2023

Mebella is another weapon in the global fight to eradicate these diseases.

Vaccines 123

Vaccines 123

Fierce Healthcare

NOVEMBER 9, 2023

​President Joe Biden's sweeping Executive Order on art | President Joe Biden's sweeping Executive Order on artificial intelligence marks a significant move to set ground rules for safety, security and privacy. But, many industry experts are skeptical about how AI can be effectively regulated given the fast pace of innovation.

122

122

Drug Topics

NOVEMBER 9, 2023

The antiviral combination nirmatrelvir-ritonavir (Paxlovid) used for early symptoms of COVID-19 offers limited protection against the development of Long COVID.

123

123

The Checkup by Singlecare

NOVEMBER 9, 2023

The U.S. Food and Drug Administration (FDA) just approved Zepbound (tirzepatide) for chronic weight management. The injectable medication is a new version of Eli Lilly’s Mounjaro, which is approved by the FDA to control blood sugar in people with Type 2 diabetes. Studies show tirzepatide works as an effective drug for people with obesity or those who are overweight and have other health conditions.

FDA 120

FDA Labelling Insurance 120

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Store News

NOVEMBER 9, 2023

Luke Rauch and Robert Tompkins are departing Walgreens, amid around 267 reported corporate layoffs.

116

116

European Pharmaceutical Review

NOVEMBER 9, 2023

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders. In July 2023, MyMD Pharmaceuticals released results from its Phase II study in sarcopenia evaluating potential of MYMD-1 ® , its first-in-class oral TNF-α inhibitor.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Immunization Process Improvement 115

Fierce Healthcare

NOVEMBER 9, 2023

Optum Rx is shifting eight different insulin products to its preferred formulary in a bid to address affordability, the company said Thursday. | Optum Rx is shifting eight different insulin products to its preferred formulary in a bid to address affordability, the company said Thursday.

115

115

Pharmaceutical Technology

NOVEMBER 9, 2023

GlobalData analyst Jemima Walker discusses key topics around cloud computing for the pharmaceutical industry.

114

114

Fierce Healthcare

NOVEMBER 9, 2023

Financial struggles at Bright Health Group and Friday Health Plans have raised concerns about how well the Affordable Care Act's (ACA's) risk adjustment program is working, especially whether it's | Financial struggles at Bright Health Group and Friday Health Plans have raised concerns about how well the Affordable Care Act's risk adjustment program is working, especially whether it's unfairly harming smaller insurers.

Insurance 111

Insurance 111

Fierce Pharma

NOVEMBER 9, 2023

Thanks to a Takeda approval Thursday, patients now have a drug to tackle a rare inherited blood clotting disorder. | The FDA has given a green light to Takeda’s Adzynma, the first recombinant protein product as a preventative or on demand enzyme replacement therapy in adults and kids with congenital thrombotic thrombocytopenic purpura.

FDA 111

FDA 111

European Pharmaceutical Review

NOVEMBER 9, 2023

Sandoz and Teva have become the first organisations to qualify for the new global Minimized Risk of Antimicrobial Resistance (AMR) certification. This programme was developed by the British Standards Institute (BSI) to verify companies that are taking the necessary steps in ensuring responsible antibiotic manufacturing in the global supply chain, helping to lower the spread of AMR.

111

111

pharmaphorum

NOVEMBER 9, 2023

Takeda bags FDA okay for Fruzaqla in colorectal cancer Phil.

FDA 111

FDA 111

Drug Store News

NOVEMBER 9, 2023

With so many new products hitting shelves this year, CEW and its members have taken it upon themselves to find the standouts of 2023.

111

111

pharmaphorum

NOVEMBER 9, 2023

Medicine, Media, Metamorphosis: How M3 is championing medical communications for modern healthcare Mike.

Communication 111

Communication 111

Fierce Healthcare

NOVEMBER 9, 2023

As pharmacy workers begin efforts to unionize, Walgreens Boots Alliance Executive Vice President and President of U.S. | Amid labor unrest and slipping financial performance, Walgreens executive John Driscoll said the company will be investing in salary and benefits improvements for its pharmacy workers.

111

111

Fierce Pharma

NOVEMBER 9, 2023

Cancer drugs buttress AstraZeneca as questions swirl around new indications aliu Thu, 11/09/2023 - 11:40

110

110

The Checkup by Singlecare

NOVEMBER 9, 2023

If you’ve ever had a sinus infection, you know how painful it can be. Symptoms like a stuffy nose, pressure or pain behind the eyes, headaches, a cough, and a sore throat, can have you looking for quick relief. The good news is there are a few ways to ease your symptoms. Sinus infections, or sinusitis, occur when the sinuses become infected with a virus or bacteria, making it difficult for mucus to drain.

Immunization 106

Immunization Mayo Clinic Hospitals Communication 106

pharmaphorum

NOVEMBER 9, 2023

FH23: AI and humanity, a relationship for the future Mike.

105

105

PharmExec

NOVEMBER 9, 2023

Solomon discusses new ways that researchers are fighting against bacterial resistance to medications.

105

105